Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 901–1,000 of 2,099
Takahashi, F., Hashimoto, Y., Kaji, A., Sakai, R., Kawate, Y., Okamura, T., Okada, H., Kitagawa, N., Nakanishi, N., Majima, S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.881877 · Cited by 16
“Muscles are the main organs responsible for glucose metabolism in the body (6).”
BackgroundLópez‐Soldado, I., Torres, A. G., Ventura, R., Martínez-Ruíz, I., Díaz‐Ramos, A., Planet, E., Cooper, D., Pazderska, A., Wanic, K., O’Hanlon, D., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102630 · Cited by 19
“T2D is characterized by insulin resistance (IR) in skeletal muscle [2], which can result from combining a genetic predisposition with obesity, a sedentary lifestyle, and an unhealthy diet [3].”
BackgroundDong, H., Wang, J., Lu, F., Xu, L., Gong, Y.-L., & Zou, X. (2013) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1560-1 · Cited by 16
Insulin Resistance - What is Myth and What is Reality?
Ionescu-Tirgoviste, C. (2011) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2011.123 · Cited by 17
Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans
Bertinat, R. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000285 · Cited by 20
“Muscle is the major site of insulin-dependent glucose uptake, and its ability to remove blood glucose is greatly impaired in the diabetic condition [72].”
BackgroundComplement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis
Ursini, F., D’Angelo, S., Russo, E., Nicolosi, K., Gallucci, A., Chiaravalloti, A., Bruno, C., Naty, S., Sarro, G. D., Olivieri, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163464 · Cited by 16
Effect of maternal periodontitis on GLUT4 and inflammatory pathway in adult offspring
Mattera, M. S. D. L. C., Chiba, F. Y., Lopes, F. L., Tsosura, T. V. S., Peres, M. A., Brito, V. G. B., Oliveira, S. H. P., Pereira, R. F., Marani, F., dos Santos, R. M., et al. (2019) · Journal of Periodontology · doi:10.1002/jper.18-0568 · Cited by 19
Park, H., Lim, J. S., & Lim, S.-K. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.8.742 · Cited by 17
“In addition, muscle is the primary site of glucose uptake after meal intake, and sarcopenia is highly associated with insulin resistance.(3) According to one study, inflammatory responses from muscles may underlie the development of insulin resistance: when the inflammatory response is inadequate as with aging muscle,…”
BackgroundeEF1A2 exacerbated insulin resistance in male skeletal muscle via PKCβ and ER stress
Guo, M., Li, Y., Wang, Y., Li, Z., Li, X., Zhao, P., Li, C., Lv, J., Liu, X., Du, X., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0051 · Cited by 16
“Insulin resistance in skeletal muscle is an initiating defect and a hallmark of obesity and type 2 diabetes mellitus (T2DM) (DeFronzo & Tripathy 2009).”
BackgroundTesauro, M., & Mazzotta, F. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00003-4 · Cited by 27
Wang, G., Yu, Y., Cai, W., Batista, T. M., Suk, S., Noh, H. L., Hirshman, M. F., Nigro, P., Li, M. E., Softic, S., et al. (2020) · Diabetes · doi:10.2337/db20-0439 · Cited by 17
“This defect is detectable years before diagnosis of the disease (2), and in offspring of parents with diabetes, skeletal muscle insulin resistance is a strong predictor for disease development (45).”
BackgroundSong, K., Zhang, Y., Ga, Q., Bai, Z., & Ge, R. (2020) · Obesity Facts · doi:10.1159/000508112 · Cited by 20
Skeletal muscle extracellular matrix remodeling with worsening glycemic control in nonhuman primates
Ruggiero, A. D., Davis, A., Sherrill, C., Westwood, B. M., Hawkins, G. A., Palmer, N. D., Chou, J. W., Reeves, T. E., Cox, L. A., & Kavanagh, K. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00240.2020 · Cited by 20
Jia, X., Huang, J., Huang, X., Li, X., Huang, M., Zhu, H., Li, G.-P., Lan, M.-L., Yu, Z., Xu, W., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8857687 · Cited by 16
“However, glucose homeostasis is broken in IR cases [14, 26].”
BackgroundChan, L., Yang, Y.-C., Lin, H.-C., Wahlqvist, M. L., Hung, Y., & Lee, M. (2021) · Nutrition · doi:10.1016/j.nut.2021.111269 · Cited by 17
He, K., Zhang, W., Hu, X., Zhao, H., Song, R., Bai, K., Shi, W., Shi, S., Shi, Z., & Yan, M. (2022) · Journal of Diabetes Research · doi:10.1155/2022/9982390 · Cited by 21
“The reason for this may be that, on the one hand, participants with a high BMI and high WC may have low muscle mass and thus a higher risk of developing diabetes, considering muscle tissue sensitivity to insulin [38].”
BackgroundYi, Y., Wang, C., Ding, Y., He, J., Lv, Y., & Chang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1101892 · Cited by 23
Vieira‐Lara, M. A., Reijne, A. C., Koshian, S., Čiapaitė, J., Abegaz, F., Talarovičová, A., van Dijk, T. H., Versloot, C. J., Bandsma, R., Wolters, J. C., et al. (2023) · Diabetes · doi:10.2337/db22-0746 · Cited by 17
Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice
Kumar, A., Harrelson, T. F., Lewis, N. E., Gallagher, E. J., LeRoith, D., Shiloach, J., & Betenbaugh, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102319 · Cited by 16
“target tissues, primarily skeletal muscle, is considered the primary reason for insulin resistance in T2DM [2].”
BackgroundIntrinsic Frequency and the Single Wave Biopsy: Implications for Insulin Resistance
Petrasek, D., Pahlevan, N. M., Tavallali, P., Rinderknecht, D. G., & Gharib, M. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815588108 · Cited by 14
“Insulin resistance has been shown to occur even years before the manifestation of diabetes or hypertension.(27) Mounting evidence suggests that insulin resistance as manifested by vascular dysfunction Figure 3.”
BackgroundScott, D. S., Joham, A. E., Teede, H. J., Gibson‐Helm, M. E., Harrison, C. L., Cassar, S., Hutchison, S. K., Ebeling, P. R., Stepto, N. K., & de Courten, B. V. (2016) · Nutrients · doi:10.3390/nu8120774 · Cited by 18
“IMAT may potentially have a greater impact on insulin resistance than visceral fat due to its proximity to skeletal muscle, which is the largest insulin sensitive tissue in the body accounting for 85% of glucose utilisation [30].”
BackgroundMicromanaging Glucose Tolerance and Diabetes
Saliani, N., Montazersaheb, S., & Montasser-Kouhsari, S. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.066 · Cited by 18
Skeletal Muscle microRNAs: Roles in Differentiation, Disease and Exercise
Sjögren, R. J. O., Niss, M. H. L. L., & Krook, A. (2017) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-72790-5_6 · Cited by 22
“Approximately half of the total body mass in healthy individuals consists of skeletal muscle, representing a substantial part of whole-body metabolism (DeFronzo and Tripathy 2009).”
BackgroundYoshida, N., Miyake, T., Yamamoto, S., Furukawa, S., Senba, H., Kanzaki, S., Koizumi, M., Ishihara, T., Yoshida, O., Hirooka, M., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0760-18 · Cited by 17
“The association between the skeletal muscle mass and glucose intolerance has been investigated in several population-based studies (4, 7, 8), and in a few cross-sectional studies, patients with diabetes were found to have a greater muscle mass than those without diabetes after accounting for body size (7, 8).”
BackgroundBello, O., Ladwa, M., Hakim, O., Marathe, C. S., Shojaee‐Moradie, F., Charles‐Edwards, G., Peacock, J. L., Umpleby, A. M., Amiel, S. A., & Goff, L. M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0636 · Cited by 16
Fine-tuning of microRNAs in Type 2 Diabetes Mellitus
Rosado, J. A., Diez-Bello, R., Salido, G. M., & Jardín, I. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205163944 · Cited by 16
The Scandinavian total ankle replacement prosthesis.
Coughlin, M. J. (2002) · PubMed · Cited by 18
Wu, H., Sui, C., Xia, F., Zhai, H., Zhang, H., Xu, H., Weng, P., & Lu, Y. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1015726 · Cited by 15
“Several studies have confirmed that IR in skeletal muscle is the primary defect in T2DM (15).”
BackgroundOh, E., Cho, N., Kang, H., Kim, S. H., Park, H. K., & Kwon, S. H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0296073 · Cited by 17
Pantothenate kinase 4 controls skeletal muscle substrate metabolism
Miranda‐Cervantes, A., Fritzen, A. M., Raun, S. H., Hodek, O., Møller, L. L. V., Johann, K., Deisen, L., Gregorevic, P., Gudiksen, A., Artati, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55036-w · Cited by 20
“S10G) and investigated binding partners by mass spectrometry, with pulldowns from PanK4 KO SkM serving as a negative control (Supplementary data 4).”
Physical training reduces cell senescence and associated insulin resistance in skeletal muscle
Podraza-Farhanieh, A., Spinelli, R., Zatterale, F., Nerstedt, A., Gogg, S., Blüher, M., & Smith, U. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102130 · Cited by 19
Janssen, J. A. M. J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189191 · Cited by 20
Silvestri, E., Glinni, D., Cioffi, F., Moreno, M., Lombardi, A., Lange, P. D., Senese, R., Ceccarelli, M., Salzano, A. M., Scaloni, A., et al. (2012) · Molecular BioSystems · doi:10.1039/c2mb25055a · Cited by 15
González-Casimiro, C. M., Cámara-Torres, P., Merino, B., Diez‐Hermano, S., Postigo, T., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Cells · doi:10.3390/cells10092446 · Cited by 15
Chaves, A., Miranda, E. R., Mey, J. T., Blackburn, B. K., Fuller, K. N. Z., Stearns, B., Ludlow, A., Williamson, D. L., Houmard, J. A., & Haus, J. M. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00229.2021 · Cited by 17
Roy, J. R., Janaki, C. S., Jayaraman, S., Vijayalakshmi, P., Balaji, T., Vijayamalathi, M., & Veeraraghavan, V. P. (2022) · Nutrients · doi:10.3390/nu14194181 · Cited by 17
“Protein kinase B/Akt is triggered to phosphorylate AS160, which enables GLUT4 to bind to the sarcolemma by either diminishing the tethering of the GLUT4 vesicle by TUG proteins or by enhancing Rab proteins to induce GLUT4 vesicle translocation to the sarcolemma [6,12].”
BackgroundStriking a gut–liver balance for the antidiabetic effects of metformin
Barroso, E., Montori-Grau, M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.04.004 · Cited by 15
“Since skeletal muscle accounts for most of the insulin-stimulated glucose use [92], the effectsofmetformin inthistissuemighthaveastrongimpacton glucoselevels.”
BackgroundPaez, H. G., Ferrandi, P. J., Pitzer, C. R., Mohamed, J. S., & Alway, S. E. (2023) · The FASEB Journal · doi:10.1096/fj.202202029r · Cited by 15
Liu, X., Liu, H., & Deng, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s418334 · Cited by 17
“Although exhausted islet β cells cannot be repaired, merely rescuing the function of the skeletal muscle is sufficient to improve IR and increase insulin sensitivity.(94,95) Fully functional skeletal muscles are required for healthy glucose homeostasis, and several studies have demonstrated that optimum efferocytosis…”
Gopal, K., Abdualkader, A. M., Li, X., Greenwell, A. A., Karwi, Q. G., Altamimi, T., Saed, C. T., Uddin, G. M., Darwesh, A. M., Jamieson, K. L., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105375 · Cited by 25
“To explore the signi fi cance of PDH in metabolic fl exi-bility, PDH was deliberately removed from skeletal muscle, which is a valuable model for studying metabolic fl exibility due to its ability to adapt fuel utilization based on the available fuel sources (13).”
Yang, Q., Wang, W.-W., Ma, P., Ma, Z., Meng, H., Adelusi, T. I., Lei-Du, Yin, X., & Lü, Q. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9473 · Cited by 22
“One of the most credible mechanisms that explain the molecular antidote of diabetes type 2 is the improvement of metabolic system with exercise in order to reduce insulin resistance prevalence in skeletal muscle (11-13).”
BackgroundEvidence for congruent impairment in micro and macrovascular function in type 1 diabetes
Irace, C., Messiniti, V., Tassone, B., Cortese, C., Barrett, E. J., & Gnasso, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187525 · Cited by 15
Knudsen, J. R., Henríquez‐Olguín, C., Li, Z., & Jensen, T. E. (2019) · Experimental Physiology · doi:10.1113/ep087545 · Cited by 17
“Insulin resistance at the level of skeletal muscle is an early hallmark during the development of type 2 diabetes (DeFronzo & Tripathy, 2009; Warram, Martin, Krolewski, Soeldner, & Kahn, 1990).”
BackgroundChen, Y., Li, C., Tsai, S.-J., & Chen, Y. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i11.1270 · Cited by 15
Chen, T., Chen, S., Wang, D., & Hung, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29021 · Cited by 17
“In addition, because skeletal muscle insulin resistance is a feature of type 2 diabetes (DeFronzo & Tripathy, 2009), an in vivo study analyzed their muscle biopsy specimens following a venous infusion of insulin and found that the PI3K/Akt activity was dramatically reduced, whereas the…”
BackgroundAmador, M. J., Meza, C., McAinch, A. J., King, G. A., Covington, J. D., & Bajpeyi, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00120 · Cited by 22
“Given that insulin resistance is often the earliest detectable impairment in glucose homeostasis before the development of type 2 diabetes (13, 37), results from the present study have important implications for reducing the burden of this disease.”
ResultKim, S.-W., Jung, W., Chung, S., & Park, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.331 · Cited by 18
Jin, H., Oh, H., Kim, J., Lee, K., Han, X., Lee, O., & Lee, B.-Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104511 · Cited by 15
Jang, J., Koh, J., Kim, Y., Kim, H., Park, S., Chang, Y., Jung, J., Wolfe, R. R., & Kim, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179735 · Cited by 17
“Combined Treatment of EAA and RET Completely Restores Impaired Insulin Sensitivity by DEX Treatment Impaired glucose metabolism and insulin sensitivity are representative side effects of DEX treatment [27], and are attributed, in part, to a loss of muscle mass and/or quality, as skeletal muscle is responsible for the…”
BackgroundGómez-Ruiz, A., Milagro, F. I., Campión, J., Martínez, J. A., & de Miguel, C. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-55 · Cited by 17
Khan, M. A. S., Khan, M. F., Kashiwagi, S., Kem, W., Yasuhara, S., Kaneki, M., Tompkins, R., & Martyn, J. (2017) · Shock · doi:10.1097/shk.0000000000000849 · Cited by 12
“Insulin resistance in skeletal muscle has been shown to contribute significantly to most, if not all to the hyperglycemia of patients with diabetes and diet-induced obesity (7, 34).”
Adult height and glucose tolerance: a re‐appraisal of the importance of body mass index
Rehunen, S., Kautiainen, H., Eriksson, J. G., & Korhonen, P. E. (2017) · Diabetic Medicine · doi:10.1111/dme.13382 · Cited by 17
Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo
Nzuza, S., Zondi, S., & Owira, P. M. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183355 · Cited by 17
Cysteine- and glycine-rich protein 3 regulates glucose homeostasis in skeletal muscle
Hernandez, A. M., Weber, N., LaBarge, S. A., Peterka, V., Doan, N. Y. T., Schenk, S., & Osborn, O. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00435.2017 · Cited by 21
Increased AQP7 abundance in skeletal muscle from obese men with type 2 diabetes
Lebeck, J., Søndergaard, E., & Nielsen, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00468.2017 · Cited by 16
“Skeletal muscle insulin resistance is a key component in the development of type 2 diabetes, and intramyocellular TG (IMTG) accumulation plays a central role in the pathophysiology of muscle insulin resistance (5).”
BackgroundLi, Z., Danchun, L., Zhang, H., Zhang, H., Chen, X.-Z., & Sun, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7925842 · Cited by 18
“The skeletal muscle is recognized as a classical insulin sensitive organ as well as a key regulator of glucose uptake [10].”
BackgroundIdebenone and T2D: A new insulin-sensitizing drug for personalized therapy
Dassano, A., Loretelli, C., & Fiorina, P. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.008 · Cited by 15
“is then followed by β-cell failure and hyperglycemia onset [1].”
BackgroundSoares, R. N., Colosio, A. L., Murias, J. M., & Pogliaghi, S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0866 · Cited by 18
Casella-Mariolo, J. R., Castagneto‐Gissey, L., Angelini, G., Zoli, A., Marini, P., Bornstein, S. R., Pournaras, D. J., Rubino, F., le Roux, C. W., Mingrone, G., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.069 · Cited by 16
“We previously demonstrated that the infusion of a liquidmeal into the mid jejunum significantly improves insulin sensitivity in subjects with obesity and in subjects with T2D [16].”
BackgroundInfluentialChoi, H., Seo, E., Yeon, M., Kim, M., Hur, H. J., Oh, B., & Jun, H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/5642149 · Cited by 16
“As skeletal muscle is the predominant tissue responsible for insulin-mediated glucose uptake [26], the increase of muscle mass might be a contributory factor to the improved insulin sensitivity.”
BackgroundMyokine Regulation of Insulin Secretion: Impact of Inflammation and Type 2 Diabetes
Ryan, A., Ciaraldi, T. P., & Henry, R. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01608 · Cited by 16
Roberts‐Thomson, K. M., Betik, A. C., Premilovac, D., Rattigan, S., Richards, S. M., Ross, R. M., Russell, R., Kaur, G., Parker, L., & Keske, M. A. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13237 · Cited by 17
Bai, Y., Zuo, J., Fang, X., Ma, R., Tian, T., Mo, F., Mu, Q., Zhang, Y., Yu, N., Bao, X., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5566053 · Cited by 16
“Skeletal muscle, accounting for the largest portion of insulin-mediated glucose uptake, utilization, and storage, is crucial in metabolic disorders [3, 4].”
BackgroundMthembu, S. X. H., Dludla, P. V., Nyambuya, T. M., Kappo, A. P., Madoroba, E., Ziqubu, K., Nyawo, T. A., Nkambule, B. B., Silvestri, S., Muller, C. J. F., et al. (2021) · Biochimie · doi:10.1016/j.biochi.2021.09.010 · Cited by 19
The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?
Wright, O. R. L., Hickman, I. J., Petchey, W. G., Sullivan, C. M., Ong, C. R., Rose, F. J., Ng, C., Prins, J. B., Whitehead, J. P., & O'Moore‐Sullivan, T. M. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0436 · Cited by 19
“Markers of peripheral insulin sensitivity were chosen, as they are more predictive of the development of diabetes (DeFronzo and Tripathy 2009), and therefore have more clinical relevance to the translation of findings.”
BackgroundBouwman, L. M. S., Fernández‐Calleja, J. M. S., Swarts, H. J. M., van der Stelt, I., Oosting, A., Keijer, J., & van Schothorst, E. M. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700315 · Cited by 13
Singh, D., Lawrence, K., Singh, S. K., Erċışlı, S., & Choudhary, R. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.03.009 · Cited by 18
Magnesium Intake, C-Reactive Protein, and Muscle Mass in Adolescents
Dong, Y., Chen, L., Gutin, B., Huang, Y., Dong, Y., & Zhu, H. (2022) · Nutrients · doi:10.3390/nu14142882 · Cited by 21
Han, E., Kim, M. K., Lee, H. W., Ryu, S. W., Kim, H. S., Jang, B. K., & Suh, Y. S. (2022) · Obesity · doi:10.1002/oby.23576 · Cited by 14
“As skeletal muscle is a major insulin-responsive target organ, and insulin stimulates the glucose disposal site [16, 28], fatty infiltration in muscle impairs insulin signaling, affecting glucose transport [29].”
BackgroundHan, S., Wu, Q., Wang, M., Yang, M., Sun, C., Liang, J., Guo, X., Zhang, Z., Xu, J., Qiu, X., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad016 · Cited by 14
“The skeletal muscle, one of the predominant sites of glucose disposal, plays a critical role in glycemic and metabolic homeostasis ( DeFronzo and Tripathy, 2009 ) .”
Köhler, Z. M., Trencsényi, G., Juhász, L., Zvara, Á., Szabó, J. P., Dux, L., Puskás, L. G., Rovó, L., & Keller-Pintér, A. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30998 · Cited by 20
“Approximately 40% of the human body is composed of skeletal muscle, which is responsible for 90% of glucose elimination after meals (DeFronzo & Tripathy, 2009).”
BackgroundGiesbertz, P., Brandl, B., Volkert, D., Hauner, H., & Skurk, T. (2023) · The FASEB Journal · doi:10.1096/fj.202101930r · Cited by 17
Mićić, B., Djordjevic, A. D., Veličković, N. A., Kovačević, S., Martić, T., Μacut, D., & Milutinović, D. V. (2023) · Biomedicines · doi:10.3390/biomedicines11061586 · Cited by 16
“Insulin resistance in skeletal muscle may occur much earlier than systemic hyperglycemia [26], and given the central metabolic role of skeletal muscle, it is considered a critical organ for the progression of systemic insulin resistance in PCOS [2,25].”
BackgroundRutkove, S. B., Chen, Z., Pandeya, S. R., Callegari, S., Mourey, T., Nagy, J. A., & Nath, A. K. (2023) · Biomedicines · doi:10.3390/biomedicines11071938 · Cited by 17
“Skeletal muscle is responsible for the post-prandial disposal of ~80% of glucose [44,45]; gpr27 KOs exhibit defects in insulin-mediated glucose uptake [40].”
BackgroundChapple, B. E., Woodfin, S., & Moore, W. (2024) · Molecules · doi:10.3390/molecules29040751 · Cited by 15
“The majority of insulin-stimulated glucose uptake takes place in skeletal muscle [80].”
BackgroundSammut, M. J., Dotzert, M. S., & Melling, C. W. J. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31419 · Cited by 19
Modest Decrease in Pgc1α Results in TAG Accumulation but not in Insulin Resistance in L6 Myotubes
Łukaszuk, B., Mikłosz, A., Chabowski, A., & Górski, J. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373975 · Cited by 14
Fang, P., Yu, M., He, B., Guo, L., Huang, X., Kong, G., Shi, M., Zhu, Y. N., Bo, P., & Zhang, Z. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.013 · Cited by 14
Sevoflurane Impairs Insulin Secretion and Tissue‐Specific Glucose Uptake In Vivo
Høyer, K. F., Nielsen, T. S., Risis, S., Treebak, J. T., & Jessen, N. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13087 · Cited by 14
Wang, Y., Fouret, G., Bonafos, B., Błachnio-Zabielska, A. U., Leroy, T., Crouzier, D., Baréa, B., Gaillet, S., Moro, C., Lecomte, J., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.021 · Cited by 14
Insulin-stimulated Rac1-GTP binding is not impaired by palmitate treatment in L6 myotubes
Stierwalt, H. D., Ehrlicher, S. E., Bergman, B. C., Robinson, M. M., & Newsom, S. A. (2018) · Physiological Reports · doi:10.14814/phy2.13956 · Cited by 13
Transcriptomic Responses of Skeletal Muscle to Acute Exercise in Diabetic Goto-Kakizaki Rats
Fu, S., Meng, Y., Zhang, W., Wang, J., He, Y., Huang, L., Chen, H., Kuang, J., & Du, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00872 · Cited by 17
Zaheri, Z., Fahremand, F., Rezvani, M. E., Karimollah, A., & Moradi, A. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103430 · Cited by 19
Determinants of intramyocellular lipid accumulation in early childhood
Michael, N., Gupta, V., Sadananthan, S. A., Sampathkumar, A., Chen, L., Pan, H., Tint, M. T., Lee, K. J., Loy, S. L., Aris, I. M., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0435-8 · Cited by 16
Lin, G., Liu, Q., Dai, A., Cai, X., Zhou, Q., Wang, X., Chen, Y., Ye, C., Li, J., Yang, D., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20200235 · Cited by 13
Etsassala, N. G. E. R., Ndjoubi, K. O., Mbira, T. J., Pearce, B., Pearce, K. M., Iwuoha, E. I., Hussein, A. A., & Benjeddou, M. (2020) · Molecules · doi:10.3390/molecules25184129 · Cited by 16
DNA Methylation Reorganization of Skeletal Muscle-Specific Genes in Response to Gestational Obesity
Prats‐Puig, A., García‐Retortillo, S., Parnau, M. P., Vasileva, F., Font‐Lladó, R., Xargay‐Torrent, S., Carreras‐Badosa, G., Mas‐Parés, B., Bassols, J., & López‐Bermejo, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00938 · Cited by 16
Effects of ketoisocaproic acid and inflammation on glucose transport in muscle cells
Mann, G., & Adegoke, O. A. J. (2021) · Physiological Reports · doi:10.14814/phy2.14673 · Cited by 18
“Insulin resistance in skeletal muscle is a main causative abnormality in the development of type 2 diabetes (DeFronzo & Tripathy, 2009).”
BackgroundKrishnan, M., Babu, S., Rajagopal, P., Nazar, S. P., Chinnaiyan, M., & Jayaraman, S. (2021) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.55.2s.119 · Cited by 16
Human FKBP5 Negatively Regulates Transcription through Inhibition of P-TEFb Complex Formation
Mall, D. P., Basu, S., Ghosh, K., Kumari, N., Lahiri, A., Paul, S., & Biswas, D. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00344-21 · Cited by 14
Indu, S., Vijayalakshmi, P., Jayaraman, S., & Rajalakshmi, M. (2021) · Molecules · doi:10.3390/molecules26226812 · Cited by 23
Mohajer, B., Moradi, K., Guermazi, A., Dolatshahi, M., Zikria, B. A., Najafzadeh, N., Kalyani, R. R., Roemer, F. W., Berenbaum, F., & Demehri, S. (2022) · European Radiology · doi:10.1007/s00330-022-09035-4 · Cited by 15
“the effects of hyperglycemia and insulin resistance on lipid and protein metabolism, mitochondrial function, and autophagy pathways in skeletal muscle [35, 36].”
BackgroundYuasa, K., Aoki, N., & Hijikata, T. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.06.009 · Cited by 16
Samaan, M. C., Anand, S. S., Sharma, A. M., Samjoo, I. A., & Tarnopolsky, M. A. (2015) · Scientific Reports · doi:10.1038/srep09154 · Cited by 16
Cheng, S.-H., Ismail, A., Anthony, J., Ng, O. C., Hamid, A. A., & Yusof, B. N. M. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/405615 · Cited by 21
“…Cheng,1 Amin Ismail,1,2 Joseph Anthony,3 Ooi Chuan Ng,3 Azizah Abdul Hamid,4 and Mohd Yusof Barakatun-Nisak1,2 1Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43300 Serdang, Selangor, Malaysia 2Research Centre of Excellence for Nutrition…”
BackgroundAn Extract of Russian Tarragon Prevents Obesity‐Related Ectopic Lipid Accumulation
Yu, Y., Mendoza, T. M., Ribnicky, D., Poulev, A., Noland, R. C., Mynatt, R. L., Raskin, I., Cefalu, W. T., & Floyd, Z. E. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700856 · Cited by 15
EFFECT OF COMBINATION OF TWO PLANT EXTRACTS ON DIABETES MELLITUS
Deepa, J., Aleykutty, N., & Jyoti, H. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i4.24100 · Cited by 14
“Normal glucose homeostasis depends on a wellbalanced interaction between tissue (muscle, liver and fat) sensitivity to insulin and insulin secretion [17].”
BackgroundMetabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice
Meister, J., Bone, D. B. J., Godlewski, G., Liu, Z., Lee, R. J., Vishnivetskiy, S. A., Gurevich, V. V., Springer, D., Kunos, G., & Wess, J. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008424 · Cited by 14
“The key feature of T2D is that blood glucose levels are elevated above the normal range.”
BackgroundInfluentialYadollah, S., Kazemipour, N., Bakhtiyari, S., & Nazıfı, S. (2017) · PubMed Central · Cited by 16
Yoshioka, K., Fujita, R., Seko, D., Suematsu, T., Miura, S., & Ono, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00330 · Cited by 14
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.